You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADCP

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 in People With Primary Ciliary Dyskinesia

Recruiting
  • Primary Ciliary Dyskinesia
    • Bern, Switzerland
      Institute of Social and Preventive Medicine (ISPM), University o
    Apr 11, 2022

    Penpulimab in Maintenance Therapy in Lymphoma

    Not yet recruiting
    • Lymphoma
    • (no location specified)
    Dec 25, 2022

    Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)

    Recruiting
    • Rheumatoid Arthritis
    • +8 more
    • COVID-19 vaccine
    • Montréal, Quebec, Canada
    • +1 more
    Jan 13, 2023

    HIV Infection Trial in New York (Colonoscopy)

    Not yet recruiting
    • HIV Infection
    • Colonoscopy
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Dec 7, 2022

    Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)

    Completed
    • Human Immunodeficiency Virus
    • Ad26.Mos4.HIV
    • +3 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Feb 7, 2022

    HIV Trial in Johannesburg (CH505TF gp120, GLA-SE adjuvant, Placebo)

    Recruiting
    • HIV Infections
    • CH505TF gp120
    • +2 more
    • Johannesburg, Gauteng, South Africa
      Perinatal HIV Research Unit (PHRU), Soweto CRS
    Apr 29, 2022

    HIV/AIDS Trial in Bangkok (N-803)

    Recruiting
    • HIV/AIDS
    • Bangkok, Thailand
      Thai Red Cross AIDS Research Centre
    Oct 4, 2021

    HIV Trial in Kericho (Env-C Plasmid DNA, HIV Env gp145 C.6980 protein, Rehydragel®)

    Active, not recruiting
    • HIV Infections
    • Env-C Plasmid DNA
    • +6 more
    • Kericho, Kenya
      Kenya Medical Research Institute/Walter Reed Project, Clinical R
    Feb 25, 2022

    B Cell Lymphoma Trial in United Kingdom (Varlilumab)

    Active, not recruiting
    • B Cell Lymphoma
    • Manchester, United Kingdom
    • +3 more
    Oct 26, 2022

    Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

    Completed
    Has Results
    • Human Immunodeficiency Virus
    • Ad26.Mos.HIV
    • +2 more
    • Bangkok, Thailand
      (unnamed)
    Dec 29, 2021

    Lung Cancer, Surgery, Circulating Tumor Cell Trial in Amsterdam, Leiden (Cetuximab)

    Not yet recruiting
    • Lung Cancer
    • +2 more
    • Amsterdam, Netherlands
    • +1 more
    Oct 19, 2021

    Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, Daratumumab)

    Recruiting
    • Multiple Myeloma
    • Edmonton, Alberta, Canada
    • +12 more
    Jan 27, 2023

    Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)

    Not yet recruiting
    • Gastric
    • Colorectal Adenocarcinoma
    • Shenyang, Liaoning, China
      Liaoning Cancer Hospital & Institute
    Nov 1, 2023

    HIV Trial (GEO-D02 DNA, MVA/HIV62B Vaccine, B63521^11 gp120)

    Withdrawn
    • HIV Infections
    • GEO-D02 DNA
    • +4 more
    • (no location specified)
    Oct 13, 2021

    HIV Infection Trial in Brazil, Peru, United States (Analytical Treatment Interruption)

    Recruiting
    • HIV Infection
    • Analytical Treatment Interruption
    • Los Angeles, California
    • +11 more
    Jan 13, 2023

    HIV Trial in San Francisco (DNA CON-S env, IHV01, Placebo)

    Withdrawn
    • HIV Infections
    • DNA CON-S env
    • +2 more
    • San Francisco, California
      Bridge HIV CRS
    Oct 13, 2021

    HIV Infection Trial in Worldwide (Analytical Treatment Interruption)

    Recruiting
    • HIV Infection
    • Analytical Treatment Interruption
    • Gaborone, Botswana
    • +10 more
    May 16, 2022

    Squamous Cell Carcinoma of Head and Neck, NSCLC, Colorectal Tumors Trial in Los Angeles (AFM24, SNK01)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +5 more
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center
    Jan 26, 2022

    Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

    Completed
    • Minimal Residual Disease
    • +3 more
    • Daratumumab
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Mar 2, 2022

    COVID-19 Vaccines Trial in Panama, Philippines, United States (UB-612, BNT162b2 vaccine, ChAdOx1-S vaccine)

    Active, not recruiting
    • COVID-19 Vaccines
    • UB-612
    • +3 more
    • Brownsville, Texas
    • +6 more
    Oct 11, 2022

    HER2-positive Breast Cancer, Operable Breast Cancer Trial in France (Trastuzumab + Paclitaxel, Pegfilgrastim)

    Recruiting
    • HER2-positive Breast Cancer
    • Operable Breast Cancer
    • Avignon, France
    • +8 more
    Jan 9, 2023

    HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

    Not yet recruiting
    • HIV-1-infection
    • VRC07-523LS
    • +7 more
    • Pathum Wan, Bangkok, Thailand
    • +1 more
    Mar 8, 2023

    Multiple Myeloma Trial in Belgium, France (Daratumumab, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Bruges, Belgium
    • +40 more
    Mar 25, 2021

    Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)

    Recruiting
    • Lupus Erythematosus Disseminatus
    • +2 more
      • Montpellier, France
      • +1 more
      Sep 5, 2022

      Resectable or Locally Advanced Borderline Pancreatic

      Active, not recruiting
      • Pancreas Cancer
      • Adenocarcinoma
        • Paris, France
          Groupe Hospitalier Paris Saint-Joseph
        Aug 19, 2022